Transcriptional and Immune Landscape of Cardiac Sarcoidosis
Jing LiuPan MaLulu LaiAna VillanuevaAndrew KoenigGregory R. BeanDawn E. BowlesCarolyn GlassMichael WatsonKory J. LavineChieh-Yu LinCardiovascular Division,Department of Medicine,Washington University School of Medicine,St. Louis,MO. (J.L.,P.M.,A.V.,A.K.,K.J.L.)Department of Pathology and Immunology,Washington University School of Medicine,St. Louis,MO. (L.L.,C.-Y.L.)Department of Cardiovascular Medicine,First Affiliated Hospital of Xi'an Jiaotong University School of Medicine,China (J.L.).Department of Pathology,Stanford University School of Medicine,CA (G.R.B.).Department of Surgery,Duke University,Durham,NC. (D.E.B.,M.W.)Department of Pathology,Duke University,Durham,NC. (C.G.)
DOI: https://doi.org/10.1161/CIRCRESAHA.121.320449
IF: 23.213
2022-09-16
Circulation Research
Abstract:Cardiac involvement is an important determinant of mortality among sarcoidosis patients. Although granulomatous inflammation is a hallmark finding in cardiac sarcoidosis, the precise immune cell populations that comprise the granuloma remain unresolved. Furthermore, it is unclear how the cellular and transcriptomic landscape of cardiac sarcoidosis differs from other inflammatory heart diseases. We leveraged spatial transcriptomics (GeoMx digital spatial profiler) and single-nucleus RNA sequencing to elucidate the cellular and transcriptional landscape of cardiac sarcoidosis. Using GeoMX digital spatial profiler technology, we compared the transcriptomal profile of CD68 + rich immune cell infiltrates in human cardiac sarcoidosis, giant cell myocarditis, and lymphocytic myocarditis. We performed single-nucleus RNA sequencing of human cardiac sarcoidosis to identify immune cell types and examined their transcriptomic landscape and regulation. Using multichannel immunofluorescence staining, we validated immune cell populations identified by single-nucleus RNA sequencing, determined their spatial relationship, and devised an immunostaining approach to distinguish cardiac sarcoidosis from other inflammatory heart diseases. Despite overlapping histological features, spatial transcriptomics identified transcriptional signatures and associated pathways that robustly differentiated cardiac sarcoidosis from giant cell myocarditis and lymphocytic myocarditis. Single-nucleus RNA sequencing revealed the presence of diverse populations of myeloid cells in cardiac sarcoidosis with distinct molecular features. We identified GPNMB (transmembrane glycoprotein NMB) as a novel marker of multinucleated giant cells and predicted that the MITF (microphthalmia-associated transcription factor) family of transcription factors regulated this cell type. We also detected additional macrophage populations in cardiac sarcoidosis including human leukocyte antigen–DR isotype + macrophages, SYTL3 (synaptotagmin-like protein 3) + macrophages and CD163 + resident macrophages. Human leukocyte antigen–DR isotype + macrophages were found immediately adjacent to GPMMB + giant cells, a distinct feature compared with other inflammatory cardiac diseases. SYTL3 + macrophages were located scattered throughout the granuloma and CD163 + macrophages, CD1c + dendritic cells, nonclassical monocytes, and T cells were located at the periphery and outside of the granuloma. Finally, we demonstrate mTOR (mammalian target of rapamycin) pathway activation is associated with proliferation and is selectively found in human leukocyte antigen–DR isotype + and SYLT3 + macrophages. In this study, we identified diverse populations of immune cells with distinct molecular signatures that comprise the sarcoid granuloma. These findings provide new insights into the pathology of cardiac sarcoidosis and highlight opportunities to improve diagnostic testing. Download figure Download PowerPoint
cardiac & cardiovascular systems,peripheral vascular disease,hematology